The steroidogenic acute regulatory protein (StAR) is the major entrance for cholesterol in mitochondria under acute stimulation. Under such circumstances, dysfunctional StAR activity can ultimately lead to lipoid congenital adrenal hyperplasia (LCAH). A complete understanding of the StAR's molecular structure and mechanism is essential to comprehend LCAH. Thus far, there is no mechanistic model that can explain experimental results at the molecular level. This is partly due to the lack of the molecular structure of StAR. The closest approximation to the StAR molecular structure is the human MLN64 which has a similar activity to StAR, has a highly homologous primary structure and for which an X-ray structure is known. In this context, we have modeled the structure of StAR through standard homology modeling procedures based on the MLN64 structure. Our StAR model shows the presence of a hydrophobic cavity of 783·9 Å 2 in surface area, large enough to fit one molecule of cholesterol. In addition, we have identified a unique charged pair, as in MLN64, lining the surface of the cavity and which could play a key role in the binding of cholesterol through the formation of an H-bond with its OH moiety. This suggests that the cholesterol-binding site of StAR is located inside this cavity. Taking into account that internal cavities are destabilizing to native protein structures and that the lining of the cavity has to become accessible in order to allow cholesterol binding, we have explored the possibility that StAR could exist in equilibrium with partially unfolded states. Using a structure-based thermodynamics approach, we show that partially folded states (with an unfolded C-terminal α-helix, and an open cavity) can be significantly populated at equilibrium and therefore allow cholesterol binding. These results are supported by recent experiments that show a loss of StAR helical character upon binding of an analog of cholesterol. Moreover, we show that the replacement of the residues involved in the charged-pair located in the binding site results in the loss of StAR activity, supporting a key role for these residues. Taken together, our results are applicable to StAR functioning both in the mitochondrial intermembrane space as well as outside the mitochondria.
Introduction
Until recently, it was believed that the ratelimiting step in steroid hormone synthesis was the conversion of cholesterol into pregnenolone by the cytochrome P450 side-chain cleavage (P450 scc) enzyme in the inner membrane of mitochondria (Farkash et al. 1986 ). However, it was discovered that the true rate-limiting step in steroidogenesis is the transfer of cholesterol from the outer mitochondrial membrane, through the aqueous intermembrane space, to the inner mitochondrial membrane where the P450 scc resides (Brownie et al. 1972 , Simpson et al. 1978 , Crivello & Jefcoate 1980 , Privalle et al. 1983 .
As potential cholesterol transferring proteins, the best candidate to date is the steroidogenic acute regulatory protein (StAR) first cloned and characterized in the MA-10 mouse Leydig tumor cell line by Clark et al. (1994) . Effectively, these authors were the first to identify StAR as being the same 30-kDa protein originally described by OrmeJohnson and colleagues (Pon et al. 1986 , Pon & Orme-Johnson 1988 , Alberta et al. 1989 , Epstein & Orme-Johnson 1991a ,b, Hartigan et al. 1995 , responsible for adrenocorticotropin hormone (ACTH)-stimulated steroidogenesis. The involvement of StAR in cholesterol translocation is supported by a number of experimental results, the most obvious being the StAR knockout mice (Caron et al. 1997 ) displaying lipoid congenital adrenal hyperplasia (LCAH). Patients with LCAH cannot synthesize adequate amounts of steroids and are characterized by cholesterol accumulation in the adrenal glands and gonads. This potentially lethal condition is now commonly attributed to a dysfunctional StAR, most importantly in the critical C-terminal region, as demonstrated by StAR mutants , Bose et al. 1996 . In humans, StAR is expressed in adrenal glands, gonads, and brain, and consists of 285 amino acids separated into two functional domains: (1) the mitochondrial import sequence responsible for its localization in mitochondria, and (2) the StAR lipid transfer (START) domain (Ponting & Aravind 1999 responsible for the transfer of cholesterol into the inner membrane of mitochondria.
START domains have been discovered and characterized for a large variety of proteins with different functions (Homma & Emori 1995 , Masucci et al. 1996 , Ponting & Aravind 1999 , Raya et al. 1999 . Of these, the human MLN64 protein may have a similar function as the human StAR in the placenta, brain, and non-steroidogenic tissues for the formation of steroids and bile acids (Bieche et al. 1996 , Moog-Lutz et al. 1997 , Watari et al. 1997 . The structure of MLN64 was recently solved by X-ray crystallography and revealed several interesting features (Tsujishita & Hurley 2000) . More importantly, the cholesterol binding site is best described as a hydrophobic tunnel formed predominantly from a U-shaped unclosed -barrel topped by the parallel C-terminal -helix. The tunnel completely traverses the entire MLN64 and has been suggested to work as an intermembrane shuttle (Tsujishita & Hurley 2000) , although the exact mechanism by which StAR mediates cholesterol transfer is still a subject of intensive research. Several mechanisms have been suggested for the action of cholesterol transfer by StAR. These include desorption, the implication of a molten globule state and the intermembrane shuttle (Stocco & Clark 1996 , Stocco 2000 , 2001 .
Desorption requires that the inner and outer mitochondrial membranes come into contact as StAR is imported into the mitochondrial matrix by its mitochondrial targeting sequence . Then, high volumes of cholesterol can be transferred from the cholesterol-rich outer membrane to the cholesterol-depleted inner membrane. This mechanism accounts for the localization of mitochondrial-imported proteins at contact points (Schwaiger et al. 1987 , Stocco & Clark 1996 , the rapid cholesterol transfer requiring little StAR, and the quick degradation of StAR by mitochondria (Clark et al. 1994 , Stocco & Clark 1996 . It does not however, account for the fact that StAR can still function without its N-terminal import sequence (Arakane et al. 1996 (Arakane et al. , 1998 . As for the molten globule state (Christensen et al. 2001 , Bose et al. 2002 , it was shown that StAR loses tertiary structure at low pH (3·5-4·0) while retaining secondary structures, suggesting that partially folded states of StAR are populated at low pH and even at pH values closer to neutrality (Christensen et al. 2001) . In this study, the authors suggest that this 'molten globular state' is important for StAR function outside mitochondria (Bose et al. 2002) . This model is in agreement with the observation that an active electrochemical force is required for the transfer of cholesterol (King et al. 1999) but the in vivo local acidic environment still remains to be proven. Finally, the intermembrane shuttle states that StAR acts as a sterol carrier, migrating between mitochondrial membranes (Tsujishita & Hurley 2000) . The molecular mechanism and structural requirement for the carrier role of StAR is still elusive. On the other hand, it appears that the structure of MLN64 may reveal key features to help understand the mode of cholesterol transport by StAR. The X-ray structure of MLN64 (Tsujishita & Hurley 2000) depicts a hydrophobic tunnel characterized by -strands forming the floor and sidewalls, topped by a C-terminal -helix and two loops. Inside the tunnel, there is an opening of the cavity such that one cholesterol molecule may fit. On the other hand, the tunnel openings are not large enough to allow a cholesterol molecule to pass through StAR. Tsujishita and Hurley (2000) suggest that transient conformational changes of the loops and/or the C-terminal -helix allow cholesterol access to the hydrophobic tunnel, a view supported by the recent crystallization of the phosphatidylinositol transfer protein
(PITP ) open conformation (Schouten et al. 2002) ; PITP is involved in the regulation of lipid and vesicular trafficking and in lipid-mediated signal transduction pathways (Cunningham et al. 1995 , Cockcroft 1999 . Importantly, in support of the C-terminal -helix transient conformational changes, it has recently been observed that there is loss of helical content in StAR upon binding of a cholesterol chromophoric analog, NBD-cholesterol .
Following the observations that (1) the C-terminal region of StAR is important for proper StAR activity , Bose et al. 1996 , (2) the C-terminal region is suggested to transiently change conformation for cholesterol binding (Tsujishita & Hurley 2000) , (3) the loss of StAR helical structure is obtained upon the binding of a cholesterol analog , (4) molten globular states of StAR are possible (Bose et al. 1999 , Christensen et al. 2001 , and (5) the C-terminal -helix in MLN64 entirely covers the putative cholesterol binding site, we investigated the possible implication of various conformational states of this C-terminal -helix in the binding of cholesterol to StAR through molecular modeling.
We show that the hamster StAR model has a hydrophobic cavity instead of a tunnel. This cavity is proposed to be the driving force for the unfolding of the C-terminal -helix revealing the cholesterol binding site. We calculate through structure-based thermodynamics (Freire 1993 , Lavigne et al. 2000 that this partially folded state could be significantly populated and that cholesterol favorably binds to it. We also observe that once cholesterol has bound to StAR, adjacent loops to the opened StAR binding site (loop 1 and the loop between -strands 1 and 2) effectively inhibit the C-terminal -helix reformation, supporting the observed loss of -helical structure upon cholesterol binding to StAR, thus allowing a rapid cholesterol transfer inside mitochondria. Finally, we show that a peculiar salt-bridge in the binding site plays a key role in cholesterol binding. This is supported by new mutagenesis results showing that cholesterol transfer can be abolished by removal of this salt-bridge.
Taken together, these results suggest a rapid unfolded StAR mechanism for the transfer of cholesterol from the outer to the inner mitochondial membranes, driven by the transmembrane cholesterol gradient; our calculations are applicable to a StAR functioning both in the mitochondrial intermembrane space and in the cytosol in the proximity of mitochondria. Thus, we propose a plausible common ground for the intermembrane shuttle and molten globule mechanisms.
Materials and methods

Modeling methodology
All calculations were performed on an SGI Octane 2 workstation and the InsightII (2000) suite of programs (Homology, Discover, Biopolymer and Builder, Accelrys, San Diego, CA, USA) to obtain all models. The amino acid sequences for the hamster and human StAR were obtained from Genbank (Accession Numbers AAB06763 and NP_000340 respectively) and aligned to the extracted amino acid sequence of MLN64 by a CLUSTAL W algorithm (Thompson et al. 1994) , and manually adjusted in Homology. The amino acid side chains of the hamster and human StAR were replaced in the MLN64 coordinate file (PDB ID number 1EM2.). The minimization calculations were performed in the absence of Coulombic potential, cross terms and morse potentials. The consistent valence forcefield (CVFF) (DauberOsguthorpe et al. 1988 ) was used for all calculations. Essentially, the minimization was completed in four steps: (1) fixed heavy (all but hydrogens) atoms, (2) fixed backbone atoms with tethered heavy atoms, (3) tethered backbone atoms, and (4) no atoms fixed. Each step was performed as follows: (1) steepest descent for 1000 iterations or until the maximum derivative is less than 0·001 kcal/Å, followed by (2) conjugate gradient for 1000 iterations or until the maximum derivative is less than 0·001 kcal/Å.
To define the cavity, we filled it with water; water molecules were discovered in the MNL64 crystal (Tsujishita & Hurley 2000) . First, a 50 Å solvent layer was added to the StAR models, upon which the cavity was placed 'over' the water molecules. All the water molecules outside the cavity volume were removed, keeping only the water molecules that fit in the cavity. These water molecules were visually identified by comparing the molecular surfaces of the water molecules as well as the cavity.
For binding studies, a cholesterol molecule was created using the Builder module in the InsightII suite. The initial planar structure was minimized using steepest descent for 1000 iterations or until the maximum derivative was less than 0·001 kcal/ Å, fixing nothing and using no Coulombic potential, cross terms and morse potentials. Thereafter, the cholesterol molecule was manually and visually placed inside the StAR cavity, as previously suggested (Tsujishita & Hurley 2000) . Due to the shape of StAR's cavity, placement of cholesterol was unambiguous. The structures were then minimized as mentioned above. The cholesterol-free native hamster and human models have been deposited in the protein data bank (PDB) and have PDB ID numbers 1 ILJ and 1 IMG respectively.
Free energy calculations
In order to calculate the Gibb's free energy difference ( G) between the native and partially unfolded states of StAR, we have used an approach called structure-based thermodynamics (Freire 1993) as implemented in the computer program STC (Lavigne et al. 2000) . This approach has been shown to allow for the identification of partially folded (unfolded) states of proteins in equilibrium with their native states and to allow for the prediction of binding free energy of ligands to proteins (Hilser & Freire 1997 , Baker & Murphy 1998 .
Briefly, we manually unfolded the C-terminal -helix of the hamster StAR model using the Biopolymer module of the InsightII suite. As a model for the unfolded state, we have used an extended conformation ( and ϕ=180 ). Then, the changes in accessible surface area ( ASA) between the 'unfolded states' and the native state were calculated using the CALC_ASA module of STC (Lavigne et al. 2000) and separated into polar (N and O) and non-polar (C and S) atoms. Using the calculated ASA and empirical functions relating changes in heat capacity ( Cp), enthalpy ( H), and entropy ( S) per unit of ASA, G between the different states were calculated using the THERMO module of STC (Lavigne et al. 2000) . Note that no changes in the protonation states were considered. We also explored loop movement above the opened StAR cavity using this same methodology. Finally, the binding constant between cholesterol and the partially unfolded state was calculated as described elsewhere (Lavigne et al. 2000) .
Rendering
All the model graphical images were created using either InsightII for molecular surfaces or Ribbons 3·0 for ribbon diagrams.
Materials for site-directed mutagenesis
All restriction and modifying enzymes were purchased from New England Biolabs (Mississauga, ON, Canada). The expression vector pcDNA3·1 Myc-His, lipofectamine and oligonucleotides were purchased from Invitrogen Canada Inc. (Burlington, ON, Canada). All vectors were amplified in XL1 Blue E. coli competent cells (Stratagene, La Jolla, CA, USA), and purified on Qiagen anion-exchange columns (Qiagen, Chatsworth, CA, USA). 12-Otetradecanoyl phorbol-13-acetate (TPA) and (Bu) 2 -cAMP (cAMP) were obtained from Sigma-Aldrich (St-Louis, MO, USA).
Hamster StAR mutagenesis by PCR
Briefly, two series of PCR amplifications were obtained using the following conditions: hot start of 5 min at 94 C (without DNA polymerase) followed by a touch down of 2 C from 94 C/70 C/72 C to 94 C/50 C/72 C, completed with 30 cycles of 94 C/50 C/72 C and a final 72 C elongation of 15 min. The first series consists of amplifying hamster StAR cDNA in two different reactions: first, a wild type (WT) upstream (sense) oligonucleotide to the downstream mutant (antisense) oligonucleotide at the site of interest for mutagenesis, and secondly a mutant sense oligonucleotide from the site of interest for mutagenesis to a WT antisense oligonucleotide. The second series consists of pooling both PCRs previously obtained, purified by agarose gel electrophoresis, and amplifying using WT 5 and 3 oligonucleotides. WT-StAR and all mutants were cloned into pcDNA3·1 Myc-His using unique EcoRI and HindIII restriction sites, and entirely sequenced between these restriction sites using a T7 sequencing kit from Amersham Pharmacia Biotech (Baie d'Urfé, QC, Canada), amplified, and purified on Qiagen anion-exchange columns.
Hamster StAR expression
Either WT or mutated StAR was transiently transfected into monkey kidney COS-1 cells (American Type Culture Collection, Rockville, MD, USA) using the lipofectamine method. Twenty-four hours before transfection the cells were harvested with pancreatin-EDTA solution (Invitrogen Canada Inc.) and plated at an initial density of 3·5 10 5 cells per 10 cm 2 well in 6-well plates. Cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 5·96 g/l HEPES, 2·2 g/l NaHCO 3 , 1 mM -glutamine, 100 IU/ml penicillin, and 100 µg/ml streptomycin sulfate. DMEM containing no FBS and no antibiotics was used for transfections. Each transfection assay received 1 µg DNA (500 ng/ml F2 construct (Harikrishna et al. 1993) containing cytochrome P450 scc/adrenodoxin reductase/ adrenodoxin and 500 ng/ml pcDNA3·1+ pcDNA3·1-StAR) and 10 µg/ml lipofectamine. Twenty-two hours after transfection cells were rinsed with PBS. Cells were then incubated for 24 h in DMEM without phenol red containing 10% dextran-coated charcoal-treated FBS and antibiotics without or with (Bu) 2 -cAMP. Media were kept for pregnenolone determination and cells for immunoblotting analyses.
Measurement of the hamster StAR activity
In this study, StAR activity is defined as the quantity of pregnenolone formed by transfected COS-1 cells in co-transfection experiments using F2 (Harikrishna et al. 1993) and StAR plasmids. Pregnenolone was analyzed by radioimmunoassay (ICN Pharmaceuticals, Diagnostics Division, Orangeburg, NY, USA). This conversion of cholesterol into pregnenolone is directly related to the rate of cholesterol transfer by StAR to P450 scc in the inner mitochondrial membrane.
Immunoblotting analysis SDS-PAGE was performed with 20 µg soluble proteins on a 12% gel and analyzed by immunoblotting (LeHoux et al. 1992 ) using a rabbit polyclonal anti-mouse StAR antibody (kindly given by Dr Dale Buchanan Hales, Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL, USA) as previously described (LeHoux et al. 1996) . This immunoglobulin was raised against a GST-fusion protein from a mouse StAR cDNA from a 208-1467 bp fragment . Cells were scraped and directly harvested in hot (100 C) Laemmli buffer (Laemmli 1970) . All samples were then passed through a 26-gauge needle, then boiled for 10 min and finally centrifuged at 12 000 g for 2 min. Soluble proteins in the supernatant were determined using the Bio-Rad Protein Assay Dye Reagent (Bio-Rad Laboratories Ltd, Mississauga, ON, Canada).
Immunoreactive proteins were detected using ECL-PLUS light emitting reagents (Amersham Pharmacia Biotech UK Ltd, Amersham Place, Little Chalfont, Bucks, UK). Autoradiograms were observed by exposing the blots to Kodax X-Omat XK films. The results were also visualized and quantified on the optical imager STORM 860 using ImageQuant software version 5·0 (Molecular Dynamics, Sunnyvale, CA, USA).
Statistical analyses
Differences between experimental groups were analyzed by ANOVA followed by Dunnett's test, using the SigmaStat program for Windows (SPSS Science, Chicago, IL, USA).
Results
Overall structure of molecular models
In order to undertake theoretical molecular modeling of proteins, a suitable alignment between a protein of known three-dimensional structure and the target protein must be obtained. In this case, the alignment of the human MLN64 with the hamster and human StAR proteins is depicted in Fig. 1 and shows a suitable identity of approximately 34% between the sequence of the hamster/human StAR and MLN64. Following the unambiguousness of the alignment, the amino acid residues of the hamster and human StAR proteins were substituted in the MLN64 coordinate file and the potential energy of the model was minimized appropriately (see Materials and methods). The stereochemical quality of the models was checked with the program PROCHECK (Laskowski et al. 1993) and was found to be excellent.
As expected, the theoretical models for the hamster and human StAR greatly resembled the crystalline structure of the human MLN64 (Tsujishita & Hurley 2000) . As demonstrated in Fig. 2 (only the hamster model shown), the prominent feature of the hamster StAR model is the U-shaped unclosed -strand barrel, topped by the parallel C-terminal -helix. Altogether, the structure is composed of four -helices and nine twisted anti-parallel -strands like the MLN64. The most significant change in the overall structure of the StAR model as compared with the human MLN64 crystal is a cholesterol binding site in the shape of an oval cavity matching the size and structure of cholesterol (Fig. 3A -cholesterol not shown); in MLN64, the cholesterol binding site is 'tunnel-like' (Tsujishita & Hurley 2000) . Amidst the mostly hydrophobic environment of the cavity, there are two charged amino acid residues (Glu168-Arg187, hamster numbering) forming a salt-bridge (Fig. 3B) , as described previously in MLN64 (Tsujishita & Hurley 2000) .
STC calculations
To get insight into the cholesterol transfer mechanism into the mitochondria, we attempted to calculate the change in free energy of various conformations of the hamster StAR model. STC is one of the very few methods applicable to model partially folded states that has been validated by others (Freire 1993 , Hilser & Freire 1997 , Baker & Murphy 1998 , Lavigne et al. 2000 . We therefore utilized STC to calculate the change in free energy of the various conformational states of our StAR model and to calculate a theoretical dissociation constant (K d ).
Free energy of cavity formation
Bearing in mind that the binding site of StAR has to become accessible and that cavities inside globular proteins destabilize the native state of proteins (Creighton 1993) , we have calculated the G for cavity formation using STC. Moreover, the water molecules discovered in the MLN64 crystal contribute to the destabilization of the hydrophobic cavity. In order to calculate the G, we manually calculated the ASA inside the binding site of the StAR cavity. Briefly, all atoms directly adjacent to the water molecules in the solvated model of the hamster StAR were visually identified. Then the hamster StAR model was 'cut' parallel to the oval binding site (Fig. 3C ) and each piece was subjected to ASA calculations separately. ASA between the 'cut state' and the native state was taken to be the solvated ASA ( ASA non-polar=627·8 Å 2 and ASApolar=156·1 Å 2 ) inside the hydrated cavity. This translates into a G of destabilization (cavity formation) of approximately 12 kcal/mol.
Partial unfolding of StAR
It is clear that StAR with a closed binding site would have to open to allow cholesterol inside. Supporting evidence for structural changes during cholesterol binding to StAR, and during cholesterol transfer inside mitochondria include: (1) the C-terminal region of StAR is important for proper StAR activity , Bose et al. 1996 ; (2) the C-terminal region as well as the loops spatially adjacent to this region are believed to transiently change conformations for cholesterol binding (Tsujishita & Hurley 2000) ; (3) molten globular states of StAR are possible (Bose et al. 1999) ; and (4) the C-terminal -helix of our StAR model entirely covers the putative cholesterol binding site as for the MLN64 crystal (Tsujishita & Hurley 2000) and should be free for movement. Yet, the most convincing discovery supporting StAR conformational changes for proper StAR activity is the loss of StAR helical structure upon the binding of a cholesterol analog in StAR . We therefore conceptualized the opening of the binding site primarily by the movement of the C-terminal -helix covering the U-shaped unclosed -barrel such as could happen in a molten globule state, driven by the G of destabilization caused by the hydrophobic cavity hydration as calculated above. In order to test this hypothesis, we modeled different conformations of the C-terminal -helix of the hamster StAR model. It is evident that any single conformation model is in effect a representation of an ensemble of conformations resulting from the dynamic nature of protein structure. Therefore, these conformational models should be seen as average structures. In the absence of cholesterol, three key conformations were considered: (A) native, (B) opened -C-terminal -helix still folded but removed from the binding site, and (C) partially unfolded -C-terminal -helix unfolded but with the rest of the molecule native. The free energy change for all the steps is indicated in Fig. 4 (A, B, and C respectively) . Note that we have subtracted the G for cavity formation from the calculated G change between state A and B; indeed, the destabilization of the native state by the cavity has to be taken into account. The net free energy change between the native state (A) and the partially unfolded state (C) is +2·61 kcal/mol. To a first approximation, i.e. considering the population (P) of this state relative to the native state according to the following equation:
we can estimate a significant relative population of approximately 2% for this partially unfolded conformation. Note that state B is less stable than state C, mostly due to the cost in conformational entropy for maintaining the helical conformation of the C-terminal -helix without tertiary interactions.
Binding of cholesterol to the partially unfolded state
Next, we have calculated the G of binding cholesterol to the partially unfolded state of StAR using STC, as described elsewhere (Lavigne et al. 2000) , and found a relatively weak K d of 9·44 10 5 M (Fig. 4, C to D) . Once cholesterol binds to the partially unfolded state of the hamster StAR protein, the free energy of the complex drops below the free energy of the native state (corrected for the cost of cavity formation). Since it was discovered that there is loss of helical character upon cholesterol binding , we simulated movement of the loops adjacent to the cholesterol binding site (loop 1 and loop between -strands 1 and 2) such as to inhibit the C-terminal -helix reformation. These loops are the only structures available for movement in the vicinity of the C-terminal -helix, as mentioned previously (Tsujishita & Hurley 2000) , that could aid in maintaining it in the unfolded state; Fig. 5 (D to E) depicts the movement of these loops and represents a partially refolded state of StAR. 
Trapping cholesterol inside the cavity of the StAR protein
Although it was observed that there is loss of helical structure upon binding of cholesterol inside , it is still conceivable that the C-terminal -helix refolds on top of the bound cholesterol. We thus simulated the refolding of the C-terminal -helix, trapping cholesterol inside StAR (Fig. 6, D to F to G) . A G for a closing reaction of the folded C-terminal -helix trapping the cholesterol inside was calculated (conformation A to G) to be 17·91 kcal/mol. As one can see, there is a dramatic stabilization of the complex. As discussed below we propose that this reaction could be involved in the shut off of the transfer.
Cholesterol binding site
As mentioned above, the cholesterol binding site of the hamster StAR model took the shape of a hydrophobic cavity and not a hydrophobic tunnel (Fig. 3) . We thus investigated the possibility that water molecules could change the binding site conformation since water molecules were discovered inside the MLN64 crystal (Tsujishita & Hurley 2000) . The model was then solvated in the binding site as well as surrounding the protein as described in Materials and methods. After minimization, the overall structure of the model and the cholesterol binding site did not alter. A cholesterol molecule was then inserted in the hamster StAR models and minimized accordingly. In the minimized complex, the 3 -OH group of cholesterol was localized adjacent to the saltbridge formed by Glu168-Arg187 as we expected (Fig. 7) . As seen, the 3 -OH group was localized <6 Å away, which is a sufficient distance for one water molecule to bridge the 3 -OH of cholesterol and the salt-bridge through hydrogen bonding.
Mutant activity alterations
The salt-bridge mutants of the hamster StAR were expressed in COS-1 cells and verified for alterations in activity. In both cases, when either of the amino acids involved in the formation of the salt-bridge were changed for a hydrophobic residue of similar volume (i.e. Glu168 Leu, and Arg187 Met), total loss of StAR activity was obtained in the absence of cAMP stimulation as compared with the mock transfections (Fig. 8A) . Under cAMP stimulation, an increase in StAR activity was obtained but this was never higher than the non-stimulated wild type indicating a critical role for this salt-bridge in the StAR-mediated transfer of cholesterol.
Mutant SDS-PAGE analysis
Whole cell extracts from the mutant hamster StAR-expressing COS-1 cells were analyzed by SDS-PAGE (Fig. 8B) . Under non-stimulated conditions, WT and mutant hamster StAR is expressed in similar proportions, as seen by the ensemble of three experiments (Fig. 8C) . Under cAMP stimulation, protein concentrations were markedly increased, similarly for all preparations. The control empty vector pcDNA3·1 did not produce detectable StAR protein but a basal StAR-independent cholesterol transfer into mitochondria was obtained (Bose et al. 1996) . Unexpectedly, different migratory patterns were obtained for the hamster StAR mutant Glu168 Leu (E168 L) preparations, which remain unexplained.
Discussion Molecular modeling and mutagenesis
As expected, the structure of the hamster and human StAR models greatly resemble the human MLN64 crystal structure. The most surprising structural difference compared with the MLN64 crystal structure was the loss of the hydrophobic tunnel replaced by a hydrophobic cavity in our StAR models, matching the overall structure of cholesterol. (Fig. 4D) ; after cholesterol binding, the loops immediately adjacent to the unfolded C-terminal α-helix (loop Ω1 and the loop between β-strands 1 and 2) cover the bound cholesterol (E), inhibiting the refolding of the C-terminal α-helix. (D) Partially unfolded StAR (same as in Fig. 4D) ; (E) partially refolded StAR with loops 'closed'. Main StAR structure drawn as white ribbons with the exception of the moveable loops in dark gray; cholesterol represented as van der Waals radii, also in dark gray. ∆G is the change in Gibb's free energy in kcal/mol. ∆Gf, folding. After all, the salt-bridge is located opposite the moveable C-terminal -helix at the bottom of the hydrophobic pocket, where it will not move and to which the 3 -OH group of cholesterol can interact as it binds to StAR. Although molten globular states are possible for StAR, a minimal structure must be maintained to mediate StAR function. Therefore, the salt-bridge can be visualized as a key component to maintain StAR in a conformation such that cholesterol will bind. This is supported by our mutational analyses of the salt-bridge, as well as the presence of a peptidase-resistant domain in the human StAR, which includes this salt-bridge (Bose et al. 1999 ). In the case where the salt-bridge is replaced by hydrophobic residues of similar volume (hamster E168 L-R187 M), total loss of StAR-dependent cholesterol transfer into mitochondria is obtained as compared with the mock transfections. This is most likely due to non-specific interactions of the hydrophobic amino acids and thus could lead to improper StAR folding altogether (Bose et al. 1996) ; the residual cholesterol transfer inside mitochondria is StAR-independent (Bose et al. 1996) .
Molecular modeling of StAR
Serine185 was thought to be a potential phosphorylation site and was thus changed into an alanine that cannot be phosphorylated; total loss of StAR-dependent cholesterol transfer was also obtained (Fleury et al., unpublished results) . To further test the hypothesis that S185 is indeed phosphorylated, we mutated S185 into aspartate and glutamate mimicking phosphorylation, and no gain in StAR activity was obtained. The only recuperation of StAR activity was obtained with the mutant S185C, where cysteine greatly resembles serine both in volume and hydrophilicity but still cannot be phosphorylated. Moreover, 2D-PAGE analyses of the S185A mutant did not reveal any differences compared with WT StAR. This clearly indicates that S185 is not phosphorylated and its control on StAR activity comes from structural alterations. Upon a closer look, S185 is located directly beneath the salt-bridge, inaccessible to solvent. It thus becomes clear that not only is the salt-bridge important, but also its immediate environment leading to its proper positioning. In summary, therefore, removal of the salt-bridge by mutagenesis could not only reduce cholesterol affinity to the StAR binding site due to loss of orientation, but could also result in improper folding of StAR altogether as demonstrated for the human StAR mutant E169 G (Bose et al. 1998 ).
Cholesterol translocation
The major reason for modeling StAR is to visualize its environment, hopefully leading to an One water molecule is depicted as a thick stick, allowing hydrogen bonding of the cholesterol's 3β-OH with Arg187. The color scheme is the same as in Fig. 3B : hydrophobic atoms in gray, potentially polar atoms in yellow, and charged atoms in red (oxygens) and blue (nitrogens). understanding of the cholesterol translocation into mitochondria. At present, two mechanisms are widely accepted: the molten globule, and the intermembrane shuttle. Here, we demonstrate the possibility of structural changes in the hamster StAR supported by theoretical molecular thermodynamics, in accordance with either of these mechanisms.
As one looks at the energy profile of the proposed states of StAR (Fig. 9) , two possible mechanisms become clear to account for either the intermembrane shuttle or the molten globular states acting outside mitochondria (Fig. 10) . First, in the mitochondrial intermembrane space, StAR is mainly in the native state (Fig. 9A) in equilibrium with approximately 2% in the partially unfolded state (Fig. 9C) . Upon stimulation (i.e. cAMP), cholesterol is mobilized to the outer mitochondrial membrane, increasing the chemical potential between the inner and outer mitochondrial membranes (Jefcoate et al. 1987) . This increased chemical gradient should be sufficient to increase 
Figure 10
Proposed StAR mechanism in the mitochondrial intermembrane space. Cholesterol is transferred into mitochondria through the flipping of StAR from the outer mitochondrial membrane (OMM) to the inner mitochondrial membrane (IMM). In the intermembrane space at contact sites, the cholesteroldeprived native StAR opens and unfolds through the movement of the C-terminal α-helix (step I, A to C). Close to the cholesterol-rich OMM, maybe even interacting with it, cholesterol binds to the exposed StAR binding site and the loops adjacent to the binding site (loop Ω1 and the loop between β-strands 1 and 2) close, covering cholesterol (step II, C to E). The StAR-cholesterol complex then flips on itself to release cholesterol in the IMM after the loops open to expose cholesterol (steps III and IV, E to D). If cholesterol is released in the IMM, then it can be recycled back to the native/partially unfolded state equilibrium for transport of another cholesterol molecule (step Va, D to C). In the event that no cholesterol gradient exists to drive the transport of cholesterol inside the IMM, the C-terminal α-helix of the partially unfolded cholesterol-bound StAR can then refold on top of cholesterol, irreversibly trapping cholesterol inside StAR (step Vb, D to G) and shutting off StAR function; equilibrium between the native and partially unfolded state of StAR is re-established (step I, A to C). The structures, their colors, and their labels are identical to Figs 4 and 6 for consistency.
the amount of cholesterol-bound StAR, shifting the equilibrium between native and partially unfolded StAR states, towards the partially unfolded state (Fig. 10C) . This is because the cholesterol-bound partially unfolded StAR is more stable than empty native StAR (Fig. 9C vs 9A) . Upon cholesterol binding, StAR partially closes through the movement of the loops (loop 1 and the loop between -strands 1 and 2 - Fig. 5E ) and maintains the observed loss of helical structure upon cholesterol binding . This partially 'refolded' state (Figs 5, 6 and 9; state E) then rotationally translates on itself (Fig. 10, step III) , now positioning the opened cholesterol-bound cavity towards the inner mitochondrial membrane to allow cholesterol to be transferred. Once flipped, StAR releases the cholesterol in the inner mitochondrial membrane and returns to the outer mitochondrial membrane where it can bind another cholesterol molecule for transfer (Fig.  10D ). In the event that the cholesterol gradient across the mitochondrial membranes is insufficient to drive the transfer of cholesterol inside mitochondria, refolding of the C-terminal -helix competes with the release of cholesterol and the recycling of StAR. In other words, if the release of cholesterol is disfavored due to a lowered chemical gradient, cholesterol remains bound to StAR long enough due to no net cholesterol transfer inside mitochondria. This allows enough time for the C-terminal -helix to refold on top of cholesterol; it is widely accepted that refolding of a helix is much slower than transient movement of loops in solvent. Yet, it is impossible at the moment to estimate the differences in energy threshold between the refolding of the C-terminal -helix and the recycling of StAR to the native state after cholesterol release (Fig. 6 , steps 4a vs 4b, and Fig.  10 , steps Va and Vb). In virtue of the large stabilization of the closed C-terminal -helix on top of the bound cholesterol in StAR (Fig. 9 G) , this step can be visualized as a rapid shut off mechanism halting StAR function, as it is irreversible. Even though these various StAR states can be located throughout the mitochondrial intermembrane, this mechanism will only function if in close proximity to 'contact sites'. In support of this, the complete human StAR has been located in the intermembrane space and the inner mitochondrial membrane facing the intermembrane space by immunoelectron microscopy (King et al. 1995) , and at mitochondrial contact sites by immunoblotting (Cherradi et al. 1997) .
Since our STC calculations have been performed in an aqueous solvent, these StAR partially unfolded states are also applicable to StAR in the cytosol (Bose et al. 2002) . In this case, StAR functions similarly to that of the intermembrane mechanism, with the exception that StAR does not rotationally translate upon itself. On the other hand, it would seem that StAR needs another unidentified factor to transfer cholesterol inside mitochondria as it does not enter mitochondria itself other than to be degraded. Recently, it has been shown that the peripheral benzodiazepine receptor (PBR) is located preferentially at approximately 70 Å from StAR on the mitochondrial cytosolic surface (West et al. 2001) , suggestive of a close interaction for cholesterol transfer inside mitochondria. Therefore, cytosolic StAR mediates cholesterol transfer inside mitochondria Figure 11 Proposed StAR mechanism in the cytosol. Cholesterol enters mitochondria through the concerted action of a cytosolic StAR with an unidentified factor (?). In this case, StAR unfolding is identical to the case where StAR is located in the mitochondrial intermembrane space (Fig. 10) , with the exception that StAR now shuttles cholesterol from the cholesterol-rich outer mitochondrial membrane to the unidentified mitochondrial factor. StAR supposedly remains outside the mitochondria until it is marked for degradation inside the mitochondria. For consistency, the structures, their colors, and their labels are identical to Figs 4, 6, and 10. OMM, outer mitochondrial membrane; IMM, inner mitochondrial membrane. by 'shuttling' cholesterol from the cholesterol-rich outer mitochondrial membrane to another factor (i.e. PBR) for subsequent cholesterol transfer inside mitochondria (Fig. 11) ; this mechanism may still be dependent on the cholesterol gradient across the outer and inner mitochondrial membranes. In this case, moreover, it is not inconceivable that cholesterol may be fed to StAR directly from the cytosol cholesterol carriers, such as the sterol carrier protein-2 (SCP-2) .
The pros and cons
The greatest downfall of our mechanism is the fact that the first 65 amino acids are unaccounted for; this N-terminal region is presently surrounded by controversy. On the one hand, it permits cholesterol transfer in the desorption mechanism . On the other hand, it has absolutely nothing to do with cholesterol transfer (Arakane et al. 1996 , Tsujishita & Hurley 2000 . Yet not too long ago, it was demonstrated by 2D-PAGE and 2-phased analyses of cholesterol metabolism, that newly synthesized complete StAR is rapidly processed to the N-terminally cleaved StAR, the form that mediates cholesterol access to P450 scc (Artemenko et al. 2001) . Several observations -that removal of the first 46 N-terminal amino acids only slightly affected protein concentrations and not StAR activity (Fleury et al., unpublished results) , that N-terminally cleaved StAR is the active form of StAR mediating cholesterol access to P450 scc (Artemenko et al. 2001) , and that through modeling we can justify the existence of molten globular StAR states -further support our mechanism. Therefore, in the case of the intermembrane shuttle, an import sequence-independent internalization of StAR into the mitochondrial intermembrane space is necessary and could be possible (Derman et al. 1993) . In the event where StAR functions outside mitochondria, StAR interactions with mitochondrial proteins are key for proper StAR function and still remain to be clearly identified. Petrescu et al. (2001) have recently observed four novel characteristics of StAR lacking the first 62 amino acids: (1) NBD-cholesterol was bound at two distinct sites, (2) loss of StAR -helical structure occurred when bound with NBD-cholesterol, (3) an average K d of about 32 nM was seen for both binding sites, and (4) NBD-cholesterol was bound inside the StAR 'tunnel'. First, the authors suggest that there is room inside the 'tunnel' for two NBD-cholesterol molecules. Following our modeling, the replacement of the tunnel by the cavity restrains its volume to permit only one cholesterol molecule. In addition, this is contradictory to previous results showing molar cholesterol binding to the human MLN64 and StAR (Tsujishita & Hurley 2000) . Therefore the second 'cholesterol' binding site seems to be an artifact from the intrinsic polar properties of the NBD-cholesterol chromophoric side-chain.
Secondly, a nanomolar K d is unlikely for StAR. Although this strong association of 'cholesterol' to StAR could explain the dissociation of cholesterol from the outer mitochondrial membrane as Petrescu et al. (2001) suggested, it cannot explain how cholesterol is released to the inner mitochondrial membrane. Furthermore, such strong interactions are against a rapid cholesterol transfer, as they would slow down StAR efficiency. On the other hand, a K d in micromolar proportions, such as our theoretical calculated K d 95 µM validated by STC, supports a rapid release of cholesterol by StAR.
Our STC calculations can account for several key points in the StAR-dependent cholesterol mechanism. First, the N-terminal mitochondrial sequence is not required for cholesterol transfer (Arakane et al. 1996 (Arakane et al. , 1998 either inside the intermembrane space or outside mitochondria in the cytosol. Secondly, a significant population of molten globular StAR is possible (Bose et al. 1999 , Christensen et al. 2001 under normal conditions for both mechanisms. Thirdly, the hydrophobic tunnel is nonexistent but rather is replaced by a hydrophobic pocket that opens through the molten globule; according to the MLN64 crystal, it was argued that the openings were too small to allow cholesterol to pass though the hydrophobic tunnel (Tsujishita & Hurley 2000) . Fourthly, the intermembrane shuttle becomes extremely rapid for the transfer of a great quantity of cholesterol in a short space of time (Artemenko et al. 2001 ) through partially unfolded states of StAR. Fifthly, there is loss of StAR helical structure upon 'cholesterol' binding . Sixthly, the C-terminal region of StAR is critical for StAR activity , Bose et al. 1996 . Seventhly, shutting off StAR-dependent cholesterol transfer inside mitochondria by irreversibly trapping cholesterol inside StAR is in agreement with the dependence of cholesterol transfer on newly synthesized StAR (Artemenko et al. 2001) . Finally, our proposed StAR unfolding is entirely consistent with similar C-terminal movement and unfolding of PITP , discovered by crystallization, to allow substrate binding (Schouten et al. 2002) .
In conclusion, we were able to enlarge our understanding of the elusive StAR-dependent cholesterol transfer into mitochondria through molecular modeling and structure-based thermodynamics. This is supported by our experimental and validated computational (Freire 1993 ) results presented here, and those of others . It is now possible to envision a global mechanism accounting for previously contradicting results.
